- Q3 sales rose 11% YoY (+12% organic) to $68.0M, driven by grafts (+20%) and shunts (+14%).
- Operating income declined 13% YoY to $17.7M (GAAP EPS $0.65 vs $0.75 in prior year; +5% adj.).
- FY26 outlook projects sales of $274.8M-$276.8M and EPS of $2.77-$2.82 alongside a $0.25/share quarterly dividend.
Why is $LMAT moving today? · SEC 8-K archive
$LMAT SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $LMAT: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $LMAT filing catalyst
Why did $LMAT trigger an AI stock catalyst alert?
$LMAT triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: LeMaitre Vascular Reports Q3 Sales of $68.0M (+11%), Guides FY26 EPS to $2.77-$2.82. Key points: - Q3 sales rose 11% YoY (+12% organic) to $68.0M, driven by grafts (+20%) and shunts (+14%). - Operating income declined 13% YoY to $17.7M (GAAP EPS $0.65 vs $0.75 in prior year; +5% adj.). - FY26 outlook projects sales of $274.8M-$276.8M and EPS of $2.77-$2.82 alongside a $0.25/share quarterly dividend.
How did $LMAT stock react after the SEC filing?
After the SEC 8-K for $LMAT, observed market reaction: T0 price $87.92. Past moves do not guarantee future results.
Where can I get real-time $LMAT SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $LMAT via Telegram and the VIP Web Terminal from €10/month.